NCT03504150

Brief Summary

This randomized controlled trial will compare the effectiveness of two online self-guided programs for youth and young adults with migraine against usual care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
424

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 20, 2018

Completed
14 days until next milestone

Study Start

First participant enrolled

May 4, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2020

Completed
Last Updated

October 16, 2018

Status Verified

October 1, 2018

Enrollment Period

1.4 years

First QC Date

April 5, 2018

Last Update Submit

October 15, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinically significant improvement (50% reduction or greater) in number of headache days in a 4-week period from baseline to 4-months post-randomization

    An electronic headache diary will be asked to be used for 4 weeks. Each day participants will be asked to record whether or not they have experienced a headache.

    At baseline and at 4-months post-randomization

Secondary Outcomes (5)

  • Statistically significant improvement in peak headache severity in a 4-week period from baseline to 4-months post-randomization

    At baseline and at 4-months post-randomization

  • Statistically significant improvement in headache-related functional impairment from baseline to 4-months post-randomization

    At baseline and at 4-months post-randomization

  • Statistically significant improvement in depressive symptomatology from baseline to 4-months post-randomization.

    At baseline and at 4-months post-randomization

  • Level of acceptability to the treatments (i.e., PRISM and SPHERE)

    At 4-months post-randomization

  • Level of acceptability to the treatments (i.e., PRISM and SPHERE)

    At 4-months post-randomization

Study Arms (3)

SPHERE

EXPERIMENTAL

It is an online self-guided comprehensive cognitive-behavioural therapy program that offers a headache diary, learning modules that teach a variety of cognitive and behavioural skills to cope better with their headaches, and a discussion forum where users may interact.

Behavioral: SPHERE

PRISM

EXPERIMENTAL

It is an online self-guided brief cognitive-behavioural therapy program that offers a headache diary and helps users discover their headache triggers and non-triggers. Then the program provides the users with a few personalized recommendations to help them to cope with their triggers.

Behavioral: PRISM

Usual care

NO INTERVENTION

Interventions

SPHEREBEHAVIORAL

Comprehensive Internet-based CBT program with no human support

SPHERE
PRISMBEHAVIORAL

Brief Internet-based CBT program with no human support

PRISM

Eligibility Criteria

Age14 Years - 40 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsParticipants will be asked: Are you: Male, Female, or I do not want to answer this question
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • aged 14-40 years
  • fluent in the English language (i.e., speaking, reading and writing);
  • for 14-17 year olds: suffer from headaches for a minimum of three months
  • for 18-40 year olds: suffer from headaches for a minimum of one year
  • suffer from migraine headaches as indicated with a score of 2 and above on the ID Migraine
  • have a Smartphone as PRISM has been designed to be accessed from a Smartphone and SPHERE encompasses the myWHI diary which has also been designed to be used from a Smartphone
  • use the Smartphone for activities other than texting and calling (e.g., email, Facebook) as the programs are designed for migraineurs who are familiar with using Smartphones and use them in their daily life
  • have daily Internet access from their Smartphone, because running the programs require an Internet connection
  • minimum of four headache days during 4 weeks that they are asked to use an electronic headache diary

You may not qualify if:

  • health care professional has not ruled out any underlying medical condition related to their headaches (e.g., head trauma, meningitis)
  • are pregnant, planning to get pregnant (in the next 4 to 6 months), or breastfeeding, as hormonal changes are known to exert potent influences on migraine headaches
  • have an impairment which compromises their ability to give informed consent
  • having been diagnosed with psychosis and/or schizophrenia, because a past or current diagnosis may likely interfere with the participants ability to fully participate in the study
  • have participated in our recent three-armed pilot RCT (i.e., any participant who consented and was randomized)
  • they complete less than 50% of daily entries (i.e., less than 14 daily entries) in an electronic headache dairy when they asked to use it for 4 weeks
  • More than 15 headache days during the 4 weeks that they are asked to use an electronic headache diary

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IWK Health Centre

Halifax, Nova Scotia, B3K 6R8, Canada

RECRUITING

MeSH Terms

Conditions

Migraine Disorders

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Anna Huguet, PhD

    IWK Health Centre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

April 5, 2018

First Posted

April 20, 2018

Study Start

May 4, 2018

Primary Completion

October 1, 2019

Study Completion

May 1, 2020

Last Updated

October 16, 2018

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will not share

Locations